Track Klotho Neurosciences, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Klotho Neurosciences, Inc. KLTOW · Stock Open Klotho Neurosciences, Inc. in new tab

0.0860 USD
P/B
0.61
ROE
-198.28
Beta
2.24
Loading chart...
Key Metrics
Book Value0.14
Price to Book0.61
Debt/Equity276.80

DCF valuation

Model fair value for Klotho Neurosciences, Inc. (KLTOW)
Result
Sign in to run the valuation for KLTOW.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–

Klotho Neurosciences, Inc. Logo Klotho Neurosciences, Inc. Analysis (KLTOW)

Is Klotho Neurosciences, Inc. a good investment? Klotho Neurosciences, Inc. (KLTOW) is currently trading at 0.0860 USD.

Investor FAQ

Does Klotho Neurosciences, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Klotho Neurosciences, Inc.?

Klotho Neurosciences, Inc. is classified as a Stock.

Company Profile

Klotho Neurosciences, Inc. develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates consist of KLTO-101 for the treatment or prevention of Alzheimer's disease; and KLTO-202, a gene therapy product for treatment and prevention of Lou Gehrig's disease. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. Klotho Neurosciences, Inc. is based in Omaha, Nebraska.

Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion